Novonix Net Worth
Novonix Net Worth Breakdown | NVX |
Novonix Net Worth Analysis
Novonix's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Novonix's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Novonix's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Novonix's net worth analysis. One common approach is to calculate Novonix's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Novonix's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Novonix's net worth. This approach calculates the present value of Novonix's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Novonix's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Novonix's net worth. This involves comparing Novonix's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Novonix's net worth relative to its peers.
Enterprise Value |
|
To determine if Novonix is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Novonix's net worth research are outlined below:
| Novonix Ltd ADR is way too risky over 90 days horizon | |
| Novonix Ltd ADR may become a speculative penny stock | |
| Novonix Ltd ADR appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 5.85 M. Reported Net Loss for the year was (74.82 M) with profit before taxes, overhead, and interest of 4.08 M. | |
| Novonix Ltd ADR has about 207.08 M in cash with (40.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Novonix Ltd ADR has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: U.S. Department of Commerce to Place 93.5 percent Antidumping Tariffs on Chinese Graphite Making the ... |
Novonix Quarterly Good Will |
|
Novonix uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Novonix Ltd ADR. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Novonix's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of October 2023 Upcoming Quarterly Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 4th of October 2023 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 30th of June 2022 Last Financial Announcement | View |
Know Novonix's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Novonix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Novonix Ltd ADR backward and forwards among themselves. Novonix's institutional investor refers to the entity that pools money to purchase Novonix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Rhumbline Advisers | 2025-03-31 | 102 | Principal Securities Inc | 2025-03-31 | 100.0 | Goldman Sachs Group Inc | 2025-03-31 | 0.0 | Jane Street Group Llc | 2024-12-31 | 0.0 | Simplex Trading, Llc | 2024-12-31 | 0.0 | Jackson Hole Capital Partners, Llc | 2025-03-31 | 0.0 | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 0.0 | Financial Connections Group, Inc. | 2024-12-31 | 0.0 | Hrt Financial Llc | 2024-12-31 | 0.0 | Millennium Management Llc | 2025-03-31 | 567.4 K | Quinn Opportunity Partners Llc | 2025-03-31 | 55 K |
Follow Novonix's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 248.45 M.Market Cap |
|
Project Novonix's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.35) | (0.33) | |
| Return On Capital Employed | (0.29) | (0.27) | |
| Return On Assets | (0.33) | (0.35) | |
| Return On Equity | (0.54) | (0.57) |
When accessing Novonix's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Novonix's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Novonix's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Novonix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Novonix Ltd ADR. Check Novonix's Beneish M Score to see the likelihood of Novonix's management manipulating its earnings.
Evaluate Novonix's management efficiency
Novonix Ltd ADR has Return on Asset of (0.139) % which means that on every $100 spent on assets, it lost $0.139. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4654) %, meaning that it generated no profit with money invested by stockholders. Novonix's management efficiency ratios could be used to measure how well Novonix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.33 in 2025. Return On Capital Employed is likely to rise to -0.27 in 2025. At this time, Novonix's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.2 M in 2025, whereas Total Assets are likely to drop slightly above 139.6 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.28 | 0.15 | |
| Tangible Book Value Per Share | 0.25 | 0.13 | |
| Enterprise Value Over EBITDA | (3.81) | (4.00) | |
| Price Book Value Ratio | 1.64 | 1.72 | |
| Enterprise Value Multiple | (3.81) | (4.00) | |
| Price Fair Value | 1.64 | 1.72 | |
| Enterprise Value | 253.9 M | 290.1 M |
The leadership approach at Novonix's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Enterprise Value Revenue 30.7746 | Revenue | Quarterly Revenue Growth (0.25) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Novonix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Novonix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Novonix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bank Of America Corp /de/ over three weeks ago Acquisition by Bank Of America Corp de of 100 shares of Novonix at 12.51 subject to Rule 16b-3 | ||
Bank Of America Corp /de/ over three months ago Discretionary transaction by Bank Of America Corp de of tradable shares of Novonix subject to Rule 16b-3 | ||
Bank Of America Corp /de/ over a year ago Disposition of tradable shares by Bank Of America Corp de of Novonix at 12.43 subject to Rule 16b-3 |
Novonix Earnings per Share Projection vs Actual
Novonix Corporate Management
| BBus CA | Financial Sec | Profile | |
| Darcy Macdougald | Pres Solutions | Profile | |
| Nicholas Liveris | Chief Officer | Profile | |
| Rashda Buttar | Chief Officer | Profile | |
| J York | Sr Devel | Profile | |
| Robert Long | Chief Officer | Profile |
Additional Tools for Novonix Stock Analysis
When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.